Skip to main content
Log in

Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

Recently ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles (NPs) have been widely used for medical applications. One of their important applications is using these particles as MRI contrast agent. While various research works have been done about MRI application of USPIOs, there is limited research about their uptakes in various organs. The aim of this study was to evaluate the biodistribution of dextran coated iron oxide NPs labelled with 99mTc in various organs via intravenous injection in Balb/c mice. The magnetite NPs were dispersed in phosphate buffered saline and SnCl2 which was used as a reduction reagent. Subsequently, the radioisotope 99mTc was mixed directly into the reaction solution. The labeling efficiency of USPIOs labeled with 99mTc, was above 99 %. Sixty mice were sacrificed at 12 different time points (From 1 min to 48 h post injections; five mice at each time). The percentage of injected dose per gram of each organ was measured by direct counting for 19 harvested organs of the mice. The biodistribution of 99mTc-USPIO in Balb/c mice showed dramatic uptake in reticuloendothelial system. Accordingly, about 75 percent of injected dose was found in spleen and liver at 15 min post injection. More than 24 % of the NPs remain in liver after 48 h post-injection and their clearance is so fast in other organs. The results suggest that USPIOs as characterized in our study can be potentially used as contrast agent in MR Imaging, distributing reticuloendothelial system specially spleen and liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Oghabian MA, Farahbakhsh NM (2010) Potential use of nanoparticle based contrast agents in MRI: a molecular imaging perspective. J Biomed Nanotechnol 6(3):203–213

    Article  CAS  Google Scholar 

  2. Wunderbaldinger P, Josephson L, Weissleder R (2002) Crosslinked iron oxides (CLIO): a new platform for the development of targeted MR contrast agents. Acad Radio 1(9):S304–S306

    Article  Google Scholar 

  3. Gharehaghaji N, Oghabian MA, Sarkar S, Darki F, Beitollahi A (2009) How size evaluation of lymph node is protocol dependent in MRI when using ultrasmall superparamagnetic iron oxide nanoparticles. J Magn Magn Mater 321(10):1563–1565

    Article  CAS  Google Scholar 

  4. Barcena C, Sra AK, Gao JM (2009) Applications of magnetic nanoparticles in biomedicine. Nanoscale magnetic materials and applications: 591–626

  5. Gwinn MR, Vallyathan V (2006) Nanoparticles: health effects–Pros and cons. Environ Health Persp 114(12):1818–1825

    CAS  Google Scholar 

  6. Oghabian MA, Jeddi-Tehrani M, Zolfaghari A, Shamsipour F, Khoei S, Amanpour S (2011) Detectability of Her2 positive tumors using monoclonal antibody conjugated iron oxide nanoparticles in MRI. J Nanosci Nanotechnol 11(6):5340–5344

    Article  CAS  Google Scholar 

  7. Feng JH, Liu HL, Bhakoo KK, Lu LH, Chen Z (2011) A metabonomic analysis of organ specific response to USPIO administration. Biomaterials 32(27):6558–6569

    Article  CAS  Google Scholar 

  8. Oghabian MA, Gharehaghaji N, Amirmohseni S, Khoei S, Guiti M (2010) Detection sensitivity of lymph nodes of various sizes using USPIO nanoparticles in magnetic resonance imaging. Nanomedicine 6(3):496–499

    Article  CAS  Google Scholar 

  9. Gharehaghaji N, Oghabian MA, Sarkar S, Amirmohseni S, Ghanaati H (2009) Optimization of pulse sequences in magnetic resonance lymphography of axillary lymph nodes using magnetic nanoparticles. J Nanosci Nanotechnol 9(7):4448–4452

    Article  CAS  Google Scholar 

  10. Firouznia K, Amirmohseni S, Guiti M, Amanpour S, Baitollahi A, Kharadmand AA, Mohagheghi MA, Oghabian MA (2008) MR relaxivity measurement of iron oxide nano-particles for MR lymphography applications. Pak J Biol Sci 11(4):607–612

    Article  CAS  Google Scholar 

  11. Oghabian MA, Guiti M, Haddad P, Gharehaghaji N, Saber R, Alam NR, Malekpour M, Rafie B (2006) Detection sensitivity of MRI using ultra-small superparamagnetic iron oxide nano-particles (USPIO) in biological tissues. Conference proceedings IEEE engineering in medicine and biology society 1:5625–5626

  12. Oghabian MA, Gharehaghaji N, Masoudi A, Shanehsazzadeh S, Ahmadi R, Majidi RF, Hosseini HRM (2013) Effect of coating materials on lymph nodes detection using magnetite nanoparticles. Adv Sci Eng Med 5(1):37–45

    CAS  Google Scholar 

  13. Shanehsazzadeh S, Lahooti A, Sadeghi HR, Jalilian AR (2011) Estimation of human effective absorbed dose of 67 Ga-cDTPA-gonadorelin based on biodistribution rat data. Nucl Med Commun 32(1):37–43

    Article  CAS  Google Scholar 

  14. Shanehsazzadeh S, Jalilian AR, Sadeghi HR, Allahverdi M (2009) Determination of human absorbed dose of 67GA-DTPA-ACTH based on distribution data in rats. Radiat Prot Dosim 134(2):79–86

    Article  CAS  Google Scholar 

  15. Gamarra LF, daCosta-Filho AJ, Mamani JB, de Cassia Ruiz R, Pavon LF, Sibov TT, Vieira ED, Silva AC, Pontuschka WM, Amaro E Jr (2010) Ferromagnetic resonance for the quantification of superparamagnetic iron oxide nanoparticles in biological materials. Int J Nanomedicine 5:203–211

    Article  CAS  Google Scholar 

  16. Weissleder R, Bogdanov A, Neuwelt EA, Papisov M (1995) Long-circulating iron oxides for MR imaging. Adv Drug Deliv Rev 16(2–3):321–334

    Article  CAS  Google Scholar 

  17. Jalilian AR, Shanehsazzadeh S, Akhlaghi M, Kamali-dehghan M, Moradkhani S (2010) Development of [In-111]-DTPA-buserelin for GnRH receptor studies. Radiochim Acta 98(2):113–119

    Article  CAS  Google Scholar 

  18. Jalilian AR, Shanehsazzadeh S, Akhlaghi M, Garousi J, Rajabifar S, Tavakoli MB (2008) Preparation and biodistribution of [Ga-67]-DTPA-gonadorelin in normal rats. J Radioanal Nucl Chem 278(1):123–129

    Article  CAS  Google Scholar 

  19. DeGrado TR, Reiman RE, Price DT, Wang SY, Coleman RE (2002) Pharmacokinetics and radiation dosimetry of F-18-fluorocholine. J Nucl Med 43(1):92–96

    CAS  Google Scholar 

  20. Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55(3):329–347

    Article  CAS  Google Scholar 

  21. Prabha S, Zhou WZ, Panyam J, Labhasetwar V (2002) Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int J Pharm 244(1–2):105–115

    Article  CAS  Google Scholar 

  22. Weissleder R, Stark D, Engelstad B, Bacon B, Compton C, White D, Jacobs P, Lewis J (1989) Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am J Roentgenol 152(1):167–173

    CAS  Google Scholar 

  23. Wang A-Y, Kuo C-L, Lin J-L, Fu C-M, Wang Y-F (2010) Study of magnetic ferrite nanoparticles labeled with [99 m]Tc-pertechnetate. J Radioanal Nucl Chem 284(2):405–413

    Article  CAS  Google Scholar 

  24. Moore A, Weissleder R, Bogdanov A Jr (1997) Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imaging 7(6):1140–1145

    Article  CAS  Google Scholar 

  25. Bengele HH, Palmacci S, Rogers J, Jung CW, Crenshaw J, Josphson L (1994) Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration. Magn Reson Imaging 12(3):433–442

    Article  CAS  Google Scholar 

  26. Lee PW, Hsu SH, Wang JJ, Tsai JS, Lin KJ, Wey SP, Chen FR, Lai CH, Yen TC, Sung HW (2010) The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles. Biomaterials 31(6):1316–1324

    Article  CAS  Google Scholar 

  27. Trubetskoy VS, Torchilin VP (1994) New approaches in the chemical design of gd-containing liposomes for use in magnetic resonance imaging of lymph nodes. J Liposome Res 4(2):961–980

    Article  CAS  Google Scholar 

  28. Di Marco M, Sadun C, Port M, Guilbert I, Couvreur P, Dubernet C (2007) Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. Int J Nanomed 2(4):609–622

    Google Scholar 

  29. Gupta AK, Gupta M (2005) Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials 26(13):1565–1573

    Article  CAS  Google Scholar 

  30. Boyer C, Whittaker MR, Bulmus V, Liu JQ, Davis TP (2010) The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications. Npg Asia Mater 2(1):23–30

    Article  Google Scholar 

  31. Jalilian AR, Panahifar A, Mahmoudi M, Akhlaghi M, Simchi A (2009) Preparation and biological evaluation of [67 Ga]-labeled-superparamagnetic nanoparticles in normal rats. Radiochim Acta 97(1):51–56

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohammad Ali Oghabian.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shanehsazzadeh, S., Oghabian, M.A., Daha, F.J. et al. Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice. J Radioanal Nucl Chem 295, 1517–1523 (2013). https://doi.org/10.1007/s10967-012-2173-4

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-012-2173-4

Keywords

Navigation